Overview Financials News + Filings Key Docs Charts Transactions Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
MESA LABORATORIES INC (MLAB)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/04/2023 |
8-K/A
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 11/04/2022 |
8-K/A
| Quarterly results |
| 12/22/2021 |
8-K/A
| Financial Statements and Exhibits Interactive Data|
Docs:
|
"Consent of Moss Adams, independent auditors for Agena Bioscience, Inc",
"Audited financial statements of Agena Bioscience, Inc., which comprise (a) the consolidated balance sheets as of December 31, 2020 and December 31, 2019; (b) the related consolidated statements of operations, comprehensive income (loss), stockholders’ equity, and cash flows for the years then ended, and (c) the related notes to the consolidated financial statements",
"Unaudited financial statements of Agena Bioscience, Inc, which comprise (a) the unaudited consolidated balance sheets as of June 30, 2021; (b) the related unaudited consolidated statements of operations, comprehensive income (loss), stockholders’ equity, and cash flows; and (c) the related notes to the consolidated financial statements. ",
"(1) Unaudited pro forma condensed combined balance sheets of Mesa as of September 30, 2021; (2) unaudited pro forma condensed combined statement of operations of Mesa for the year ended March 31, 2021; (3) unaudited pro forma condensed combined statement of income of Mesa for the six months ended September 30, 2021; and (4) related notes to unaudited pro forma condensed combined financial statements" |
|
| 01/15/2020 |
8-K/A
| Financial Statements and Exhibits|
Docs:
|
"Consent of Plante & Moran, PLLC",
"(A) Unaudited pro forma condensed combined consolidated balance sheets of the Company as of September 30, 2019, (B) the unaudited pro forma condensed combined consolidated statement of operations of the Company for the year ended March 31, 2019, (C) the unaudited pro forma condensed combined consolidated statements of income of the Company for six months ended September 30, 2019, (D) the related notes to unaudited pro forma condensed combined consolidated financial statements",
"Audited financial statements of Gyros Protein Technologies Holding AB, which comprise (A) the balance sheets as of December 31, 2018 and 2017; (B) the related statements of income, comprehensive income, stockholders’ equity, and cash flows for the years then ended; and (C) the related notes to the financial statements",
"Unaudited financial statements of Gyros Protein Technologies Holding AB, which comprise (A) the balance sheet as of June 30, 2019; (B) the related statements of income, comprehensive income, stockholders’ equity, and cash flows for the six months ended June 30, 2019 and June 30, 2018, respectively; and (C) the related notes to the financial statements" |
|
| 08/05/2019 |
8-K/A
| Other Events, Financial Statements and Exhibits |
| 11/06/2018 |
8-K/A
| Submission of Matters to a Vote of Security Holders |
| 07/27/2012 |
8-K/A
| Form 8-K/A - Current report [Amend] |
| 07/29/2010 |
8-K/A
| Form 8-K/A - Current report [Amend] |
| 07/12/2010 |
8-K/A
| Financial Statements and Exhibits|
Docs:
|
"SGM BIOTECH, INC. AND AFFILIATE Consolidated Financial Statements and Independent Auditors' Report December 31, 2009 and 2008 SGM BIOTECH, INC. AND AFFILIATE",
"UNAUDITED PRO FORMA COMBINED STATEMENT OF OPERATIONS AND UNAUDITED PRO FORMA COMBINED BALANCE SHEET The following unaudited pro forma combined balance sheet as of March 31, 2010 and the unaudited pro forma combined statement of operations for the year ended March 31, 2010 give effect to Mesa Laboratories, Inc.'s acquisition of all the issued and outstanding shares of common stock of SGM Biotech, Inc. and the purchase of real estate held by SGM's affiliate, Surreal, LLC, effective April 27, 2010, including the related pro forma adjustments described in the notes thereto. The unaudited pro forma balance sheet has been prepared as if the transaction was recorded on Mesa's books as of March 31, 2010. The unaudited pro forma combined statement of operation has been prepared as if the proposed t..." |
|
| 07/20/2006 |
8-K/A
| Form 8-K/A - Current report [Amend] |
|
|